OD-07656, OD-07656, Entyvio 300 mg powder for concentrate for solution for infusion
OD-07656-201
Phase 2 small_molecule active
Quick answer
OD-07656, OD-07656, Entyvio 300 mg powder for concentrate for solution for infusion for Moderately to Severely Active Ulcerative Colitis is a Phase 2 program (small_molecule) at Odyssey Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Odyssey Therapeutics
- Indication
- Moderately to Severely Active Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active